Cancer Innovation: $SINT and $MYNZ in Focus$SINT is making waves with its development of cancer treatment devices, tapping into a $150B oncology market. Meanwhile, $MYNZ is carving out a niche in diagnostics, with advanced cancer detection solutions targeting early intervention. Both have solid growth drivers.